Clinical Trial Update: Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting on a combination of cisplatin, paclitaxel, and everolimus in metastatic breast cancer with Phase 1 and Phase 2 results completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Everolimus (everolimus)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-03-11